Do Bitcoin halvings matter? Strategy buys outpace new BTC supply by 700%
Strategy bought seven weeks of new Bitcoin supply in one week, boosting the case for a $400,000 BTC price target if this pace continues.
Crypto.com taps KG Inicis for tourist crypto payments in South Korea
The partnership targets foreign travelers in South Korea, adding real-world merchant access through a major local payments processor.
South Korea police draft crypto seizure rules after custody lapses: Report
Local media outlet Asiae reported that the national police aim to select a private custody provider in the first half of 2026.
Ex-LA cop gets 5 years prison for helping crypto ‘Godfather’ extort victims
Michael Coberg was sentenced to 63 months in prison for his role in helping the so-called crypto “Godfather” with a sham drug bust and the extortion of a victim for $127,000.
DeFi lobby drops airdrop lawsuit against SEC, citing crypto shift
The voluntary dismissal was filed without prejudice, meaning Beba and the DeFi Education Fund could refile the same case at a later date.
Messari’s new CEO is doubling down on AI as firm cuts staff
“We’re doubling down on Messari as an AI-first company serving institutions through research and AI products,” said Messari’s new CEO, Diran Li on Monday.
US Bitcoin ETFs post 6-day inflow streak as crypto rallies
US-listed spot Bitcoin ETFs have tallied nearly $1 billion worth of inflows since March 9, with Bitcoin rising more than 12% to $74,250 in that time.
Trump ups pressure for Fed chair Powell to cut rates ‘right now’
“What’s a better time to cut interest rates than now? A third-grade student would know that,” said US President Donald Trump.
SEC seeks comment on crypto handling in OTC broker-dealer rule
The SEC has proposed narrowing Rule 15c2-11 to equity securities only, and is now seeking comment on whether it should apply to certain crypto assets, among other questions.
Wife used CCTV to steal $176M of husband’s crypto, UK court told
Justice Cotter said in his judgment that the husband in the case has a high chance of succeeding, given the available evidence and recommended an early trial.